Cyclin-Dependent Kinase 4 Phosphorylates and Positively Regulates PAX3-FOXO1 in Human Alveolar Rhabdomyosarcoma Cells

Liu, Lingling; Wu, Jing; Ong, Su Sien; Chen, Taosheng
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Alveolar rhabdomyosarcoma (ARMS) is an aggressive childhood muscle sarcoma with a 5-year survival rate of less than 30%. More than 80% of ARMSs harbor a PAX3-FOXO1 fusion transcription factor. However, expression of PAX3-FOXO1 in muscle cells alone is not sufficient and requires the loss of function of Ink4a/ARF to promote malignant proliferation of muscle cells in vitro or initiate ARMS tumor formation in vivo. This prompted us to examine the signaling pathways required to activate the function of PAX3-FOXO1 and to explore the functional interaction between the Ink4a/ARF and PAX3-FOXO1 signaling pathways. Here we report that inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin (a small molecule selective inhibitor of Cdk4/cyclin D1 that we identified in a screen for compounds that inhibit PAX3-FOXO1) led to inhibition of the transcriptional activity of PAX3-FOXO1 in ARMS cell line Rh30. Consistent with this finding, activation of Cdk4 enhanced the activity of PAX3-FOXO1. In vitro kinase assays revealed that Cdk4 directly phosphorylated PAX3-FOXO1 at Ser430. Whereas fascaplysin did not affect the protein level of PAX3-FOXO1, it did increase the cytoplasmic level of PAX3-FOXO1 in a portion of cells. Our findings indicate that Cdk4 phosphorylates and positively regulates PAX3-FOXO1 and suggest that inhibition of Cdk4 activity should be explored as a promising avenue for developing therapy for ARMS.


Related Articles

  • Alveolar rhabdomyosarcoma - The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis. Marshall, Amy D.; Grosveld, Gerard C. // Skeletal Muscle;2012, Vol. 2 Issue 1, p1 

    Rhabdomyosarcoma is a soft tissue sarcoma arising from cells of a mesenchymal or skeletal muscle lineage. Alveolar rhabdomyosarcoma (ARMS) is more aggressive than the more common embryonal (ERMS) subtype. ARMS is more prone to metastasis and carries a poorer prognosis. In contrast to ERMS, the...

  • Cdc2p controls the forkhead transcription factor Fkh2p by phosphorylation during sexual differentiation in fission yeast. Shimada, Midori; Yamada-Namikawa, Chisato; Murakami-Tonami, Yuko; Yoshida, Takashi; Nakanishi, Makoto; Urano, Takeshi; Murakami, Hiroshi // EMBO Journal;1/9/2008, Vol. 27 Issue 1, p132 

    In most eukaryotes, cyclin-dependent kinases (Cdks) play a central role in control of cell-cycle progression. Cdks are inactivated from the end of mitosis to the start of the next cell cycle as well as during sexual differentiation. The forkhead-type transcription factor Fkh2p is required for...

  • Retinoblastoma protein goes green: the role of RBR in Arabidopsis meiosis. Kurzbauer, Marie-Therese; Schlögelhofer, Peter // EMBO Journal;2/16/2011, Vol. 30 Issue 4, p631 

    No abstract available.

  • Pol II CTD kinases Bur1 and Kin28 promote Spt5 CTR-independent recruitment of Paf1 complex. Qiu, Hongfang; Hu, Cuihua; Gaur, Naseem A; Hinnebusch, Alan G // EMBO Journal;8/15/2012, Vol. 31 Issue 16, p3494 

    Paf1 complex (Paf1C) is a transcription elongation factor whose recruitment is stimulated by Spt5 and the CDKs Kin28 and Bur1, which phosphorylate the Pol II C-terminal domain (CTD) on Serines 2, 5, and 7. Bur1 promotes Paf1C recruitment by phosphorylating C-terminal repeats (CTRs) in Spt5, and...

  • The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycle.  // Cell Division;2012, Vol. 7 Issue 1, p10 

    The article offers information on the retinoblastoma (RB) family of proteins, and their regulatory functions in mammalian cell division cycle. It states that the RB1 gene frequently gets inactivated in cancer through alterations to cyclin dependent kinase regulation, but in small cell lung...

  • DNA damage: The road of death. Heinrichs, Arianne // Nature Reviews Molecular Cell Biology;Dec2006, Vol. 7 Issue 12, p878 

    The article reports the research on the role of Cyclin-dependent kinase-2 (CDK2) in DNA-damage-induced cell death. Researchers Donald Tindall and colleagues have found that CDK2-mediated phophorylation of the transcription factor FOXO1 regulates apoptosis following DNA damage. The authors...

  • CDK-Mediated Regulation of Cell Functions via c-Jun Phosphorylation and AP-1 Activation. Bush, Tony J. Vanden; Bishop, Gail A. // PLoS ONE;2011, Vol. 6 Issue 4, p1 

    Cyclin-dependent kinases (CDKs) and their targets have been primarily associated with regulation of cell-cycle progression. Here we identify c-Jun, a transcription factor involved in the regulation of a broad spectrum of cellular functions, as a newly recognized CDK substrate. Using immune cells...

  • The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27Kip1 and control of cyclin D1 expression. Cappellini, A.; Tabellini, G.; Zweyer, M.; Bortul, R.; Tazzari, P. L.; Billi, A. M.; Falà, F.; Cocco, L.; Martelli, A. M. // Leukemia (08876924);Nov2003, Vol. 17 Issue 11, p2157 

    The serine/threonine protein kinase Akt, a downstream effector of phosphoinositide 3-kinase (PI3K), plays a pivotal role in tumorigenesis because it affects the growth and survival of cancer cells. Several laboratories have demonstrated that Akt inhibits transcriptional activation of a number of...

  • Antidiabetic actions of a non-agonist PPAR? ligand blocking Cdk5-mediated phosphorylation. Jang Hyun Choi; Banks, Alexander S.; Kamenecka, Theodore M.; Busby, Scott A.; Chalmers, Michael J.; Kumar, Naresh; Kuruvilla, Dana S.; Youseung Shin; Yuanjun He; Bruning, John B.; Marciano, David P.; Cameron, Michael D.; Laznik, Dina; Jurczak, Michael J.; Schürer, Stephan C.; Vidović, Dušica; Shulman, Gerald I.; Spiegelman, Bruce M.; Griffin, Patrick R. // Nature;9/22/2011, Vol. 477 Issue 7365, p477 

    PPAR? is the functioning receptor for the thiazolidinedione (TZD) class of antidiabetes drugs including rosiglitazone and pioglitazone. These drugs are full classical agonists for this nuclear receptor, but recent data have shown that many PPAR?-based drugs have a separate biochemical activity,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics